Diseases, Conditions, Syndromes

Doctor details two new hepatitis C drugs

In the last three weeks, the Food and Drug Administration has approved two new drugs that are expected to dramatically improve treatment of chronic hepatitis C, a liver-damaging viral infection that afflicts more than 3.2 ...

Diseases, Conditions, Syndromes

MERS-CoV treatment effective in monkeys, study finds

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more ...

Diseases, Conditions, Syndromes

Sofosbuvir shows promise for chronic hepatitis C infection

(HealthDay)—Sofosbuvir seems to be a promising treatment option for patients with chronic hepatitis C virus (HCV) infection, according to two studies published online April 23 in the New England Journal of Medicine to coincide ...

Diseases, Conditions, Syndromes

Treatment for novel coronavirus shows promise in early lab tests

National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown ...

Diseases, Conditions, Syndromes

Interferon-free therapies for hep C virus look promising

(HealthDay)—For untreated patients with hepatitis C virus (HCV), treatment with an oral nucleotide inhibitor of HCV polymerase, sofosbuvir, plus ribavirin seems effective for genotypes 1, 2, and 3; and the HCV NS3 protease ...

Medications

Abbott Labs rises on hepatitis C drug data (Update)

Abbott Laboratories said Monday that its experimental hepatitis C drug regimen cured 99 percent of patients in a midstage study with the most common and hardest-to-treat type of the disease.

Diseases, Conditions, Syndromes

Prior alcohol consumption does not impair HCV treatment

(HealthDay)—For patients with hepatitis C virus (HCV) treated with pegylated interferon-alpha and ribavirin (P/R), drinking patterns and the amount of alcohol consumed before treatment do not impact treatment success, according ...

Diseases, Conditions, Syndromes

Will new drugs block hepatitis C virus in its tracks?

Targeted multi-drug treatments for hepatitis C patients that could stop the virus in its tracks have come a step closer, thanks to researchers at the University of Leeds, UK.

page 3 from 4